Arbutus Biopharma (ABUS) - Clinical-Stage, IP-Centric Biopharma
A Binary Biotech Play?
Biotech
Particles, Patents, Pandemics, and Plaintiffs
What Lies Beneath
Incyte (INCY) – Q3 - 2025 Review
Another Pharma Patent Cliff Rebuild Story?
Pfizer ( PFE ) – Q3 2025 Review
The Stock That Fell To Earth
Q: Is There A Generational Opportunity In Biotech Stocks?
Biotech 2026 = Tech 2023?
Regeneron (REGN) – Q3 2025 Review
Eyeing A Breakout?
Novo Nordisk (NVO) - Q3 FY12/25 Earnings Review
Definitely Some Hair On This One
Initiating Coverage Of Merck & Co (MRK).
More evidence of rotation into healthcare stocks
ADMA Biologics Q2 FY12/25 Earnings Review
Running With The Big Dogs
BioNTech (BNTX): More Than a One Hit Wonder?
Another 90% Club Member